The C1QTNF5 gene helps support the layer of cells under the retina that nourishes light sensing cells and keeps the back of the eye stable. If it does not work properly, material can collect under the retina and central vision may slowly worsen, often in adulthood. Pathogenic variants are linked to late-onset retinal degeneration, an inherited eye condition that can affect reading, driving, and seeing in dim light.
What is a gene?
Genes are stretches of DNA that give your cells instructions for making molecules or directing processes in the body. Some genes carry the directions for producing proteins, which are the parts of cells that do much of the work. Others mainly control when certain processes take place, where they occur, and how strongly they run. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, and medications. You can find more on this topic in the LearnHub.
Overview
C1QTNF5Gene function
What if the gene works
The C1QTNF5 gene helps retinal support cells stay attached to the thin layer beneath them. This helps the retina stay stable and supports the layer that nourishes light sensing cells.
Risk
What if the gene does not work
Variants in the C1QTNF5 gene are linked to late onset retinal degeneration, an inherited eye condition that can reduce central and night vision. Milder and more severe variants may affect the age symptoms begin and how much vision changes.
Treatment
What does that mean for your treatment
No C1QTNF5-specific treatment or drug selection approach is currently established in clinical guidelines. Care is supportive and guided by eye findings rather than the specific variant. The C1QTNF5 gene is being studied as a possible target for retinal therapies, including early-stage gene-based approaches.
Conditions associated with C1QTNF5
Gene function
What if the gene works
In the back of the eye, the C1QTNF5 gene helps support the cell layer that nourishes the retina. Its protein is released outside cells, where it helps nearby tissues stay organized and connected. This helps explain how the C1QTNF5 gene supports the retina during everyday vision.
Retinal pigment cells use the C1QTNF5 gene to make a protein that is released into the space around them. There, it supports the local environment that helps the retina do its routine work.
Protein from the C1QTNF5 gene helps retinal pigment cells stay attached to Bruch membrane, the thin support sheet under this layer. A steady connection helps the back of the eye keep its usual structure.
After it is released, this protein becomes part of the material outside cells at the back of the eye. This contributes to a stable, orderly space between the retina and its support tissues.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, such as differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can affect how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the C1QTNF5 gene can change the protein’s shape, making it fold abnormally, stick to itself, and leave retinal support cells less effectively. In late-onset retinal degeneration, this shows how C1QTNF5 gene variants affect protein folding and secretion, with abnormal material building up near the retina. Some variants may have a milder effect on protein stability, while more disruptive changes can cause stronger clumping and may be linked to earlier or more marked disease.
How variants are linked to conditions
Pathogenic variants in the C1QTNF5 gene cause late-onset retinal degeneration, a rare inherited eye condition. Late-onset retinal degeneration caused by C1QTNF5 gene variants usually appears in midlife and can bring night vision problems, blind spots, and gradual loss of central vision. It often runs in families, and a parent carrying the variant may pass it to a child.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and instead reflect natural human variation. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors also play a role. In some situations, though, a single well characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For inherited C1QTNF5 changes linked to late-onset retinal disease, the chance of developing the condition is driven mainly by the genetic change itself and family history. There is not enough evidence to say that diet, exercise, or other lifestyle steps lower this risk, but regular eye checks can help find changes and complications early.
Inheritance of C1QTNF5 variants
C1QTNF5 gene variants linked to inherited retinal disease are usually passed down in an autosomal dominant pattern. This means a person needs one altered copy of the C1QTNF5 gene to have the condition, and each child of an affected parent has a 50% chance of inheriting that variant. In practical terms, the variant can be passed from a mother or a father to a son or daughter. When people ask how C1QTNF5 gene variants are inherited, the usual answer is that they tend to run through families across generations.
What does my C1QTNF5 result mean for my family?
A disease-causing change in the C1QTNF5 gene is linked to a rare inherited eye condition that usually runs in families in a dominant pattern. This means close relatives, such as a parent, brother, sister, or child, may also carry the same genetic change and could develop similar vision problems over time. Because of that, family members may want to discuss genetic testing and eye screening with their care team.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the C1QTNF5 gene, genetic testing for C1QTNF5 variants uses a blood or saliva sample. A lab reads the DNA sequence and compares it with the usual gene code. Results may identify a disease-causing variant, show no relevant variant, or find a variant of uncertain significance.
When should I consider getting a genetic test?
Consider genetic testing for C1QTNF5 if several relatives have had a rare inherited eye condition with trouble seeing at night and gradual vision loss in adulthood, or if you have these findings yourself. A confirmed change in this gene can help explain the cause and clarify whether it runs in the family.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, but how much it explains depends on the condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body works. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is most helpful when viewed alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can help place personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the body, or responds to it at the target tissue. This helps explain why the same medication may work well for one person, have less effect in another, or cause more side effects in someone else. These differences are common and are one reason treatment response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how inherited genetic differences can shape a person’s response to medicines. By studying links between genes and specific drugs, it helps explain why the same treatment may work differently in different people. With many medications, genes can affect how powerfully a drug works or how the body handles it. That information can support treatment decisions that are both better informed and more personalized. More on this topic is available in the LearnHub.
Drugs influenced by the C1QTNF5 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so any concerns about your health or medicines are best discussed with your doctor.
History
C1QTNF5 entered the genetics literature through studies of families with an inherited eye condition now known as late onset retinal degeneration. Initially understood only through visible traits, later recognized as tied to a specific gene, this discovery helped connect a distinctive retinal pattern with a shared hereditary cause. Researchers first described the condition in affected families and then identified a disease linked variant in the C1QTNF5 gene in the early 2000s. From these first observations, research expanded steadily, including work in animal models and retinal tissue that clarified how the finding fit into inherited retinal disease. The gene is also known in older papers as CTRP5, reflecting how naming changed as knowledge of the gene family developed.